The serum concentrations of galectin-3 and -4 are increased, but galectin-1 in the cerebrospinal fluids is decreased in patients with Parkinson's disease (Cengiz et al., 2019; Marques et al., 2019; Yazar et al., 2019). This evidence concerns the gene LGALS1 and Parkinson disease.